<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02705560</url>
  </required_header>
  <id_info>
    <org_study_id>347/15</org_study_id>
    <nct_id>NCT02705560</nct_id>
  </id_info>
  <brief_title>Assessment of Dietary Biomarkers and Metabolic Effects After the Intake of Milk and Cheese</brief_title>
  <official_title>Randomized, Controlled, Cross-Over Study to Assess Dietary Biomarkers and Metabolic Effects After a Single Dose of Milk and Cheese in Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Vaudois</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Agroscope Liebefeld-Posieux Research Station ALP</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire Vaudois</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dietary biomarkers are compounds in biofluids that directly reflect the intake of specific&#xD;
      foods or food groups. Their exploration and use in the field of dietary assessments could&#xD;
      provide an objective measure of actual intake complementing classical assessment methods&#xD;
      (e.g. food frequency questionnaire, 24h recalls). To date, only a limited number of foods&#xD;
      have been covered by validated biomarkers.&#xD;
&#xD;
      The study is part of the international project &quot;The Food Biomarker Alliance (FOODBALL)&quot;. The&#xD;
      study described here has been assigned to assess biomarkers of the intake of milk and cheese.&#xD;
      Up to now, there is an evident lack of data on specific and validated biomarkers of milk and&#xD;
      cheese (dairy products), which belong to the most relevant public health related foods in&#xD;
      Europe. This study will further provide novel insights into the influence of fermentation of&#xD;
      milk-based foods on metabolic effects and postprandial adaptations, which has not yet been&#xD;
      studied in depth before using cheese as fermented product. Outcomes will support and expand&#xD;
      earlier findings on correlation between the intake of fermented dairy products intake and&#xD;
      human health.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an acute, randomized, controlled, cross-over study designed to identify dietary&#xD;
      biomarkers of milk and cheese intake and to asses metabolic effects after the ingestion of a&#xD;
      non-fermented product (milk) and a fermented product (cheese) in healthy subjects.&#xD;
&#xD;
      Twelve healthy participants (six women, six men) in fasted state will consume three different&#xD;
      foods in a randomized order on three different study days. Two days prior to each dietary&#xD;
      intervention, the run-in period is initiated, during which participants have to follow a&#xD;
      restricted diet. Participants will receive a standardised meal for the last dinner during&#xD;
      run-in phase. The same meal will be served on the day of the dietary intervention for lunch&#xD;
      and for dinner (period of controlled diet). Before and after ingestion of the test foods,&#xD;
      blood samples and urine samples will be collected (up to 6 hours). Additionally, 24h-samples&#xD;
      will be collected. Primary outcomes (metabolites) will be measured in blood serum and plasma&#xD;
      collected at 6 different time points and in urine collected at 7 different time points.&#xD;
      Transcriptomics analysis will be performed on whole blood samples collected at 4 time points&#xD;
      while clinical chemistry parameters will be assessed in blood samples withdrawn at 6&#xD;
      different time points.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Identification of dietary biomarkers of cheese and milk intake</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Transcriptomics analyses / gene expression</measure>
    <time_frame>6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood cell count and cell type determination</measure>
    <time_frame>6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triacylglycerides</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total cholesterol</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HDL cholesterol</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LDL cholesterol</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Cow´s milk (3.9% fat, pasteurized)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cow´s milk (3.9% fat, pasteurized) Single dose, 600 ml milk</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hard, yellow cheese</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hard, yellow cheese Single dose, 100 g cheese&#xD;
+ 500 ml water</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Soy based drink</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Soy based drink Single dose, 600 ml soy drink (soy drink + plant based cream)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cow´s milk (3.9% fat, pasteurized)</intervention_name>
    <description>600 ml full fat milk (organic, pasteurized, 400 kcal)</description>
    <arm_group_label>Cow´s milk (3.9% fat, pasteurized)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>hard, yellow cheese</intervention_name>
    <description>100 g Swiss cheese (Le Gruyère medium ripe, 400 kcal)</description>
    <arm_group_label>Hard, yellow cheese</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Soy based drink</intervention_name>
    <description>600 ml Soy drink (540 ml soy milk (232 kcal) supplemented with 60 ml soy and plant based cream (167 kcal)</description>
    <arm_group_label>Soy based drink</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy males and females&#xD;
&#xD;
          -  Aged 18 - 40 years&#xD;
&#xD;
          -  BMI &gt; 18.5 and &lt; 30 kg/m2&#xD;
&#xD;
          -  Daily consumption of milk&#xD;
&#xD;
          -  No adverse effects after intake of 600 ml of milk&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smokers&#xD;
&#xD;
          -  Diagnosed health condition (chronic or infectious disease)&#xD;
&#xD;
          -  Taking medication (oral contraceptive pill is allowed)&#xD;
&#xD;
          -  Taking nutritional supplements (e.g. vitamins, minerals)&#xD;
&#xD;
          -  Pregnant, lactating&#xD;
&#xD;
          -  Antibiotics treatment 6 months prior to intervention&#xD;
&#xD;
          -  Allergy to milk&#xD;
&#xD;
          -  Allergy to soy&#xD;
&#xD;
          -  Known intolerance to lactose&#xD;
&#xD;
          -  Other food allergies or intolerances (e.g. histamine)&#xD;
&#xD;
          -  Anemia (hemoglobin &lt; 120 g/l) at the screening visit&#xD;
&#xD;
          -  Iron deficiency (ferritin &lt; 30 µg/l) at the screening visit&#xD;
&#xD;
          -  Not willing/able to consume all test foods (milk, cheese and soy drink)&#xD;
&#xD;
          -  Not willing/able to consume standardized meals&#xD;
&#xD;
          -  Not willing to avoid drinking alcohol during study days&#xD;
&#xD;
          -  Not willing to follow nutritional restrictions during study days&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>François Pralong, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHUV</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>François Pralong, MD</last_name>
    <phone>004121 314 05 96</phone>
    <email>francois.pralong@chuv.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Linda Münger, PHD</last_name>
    <phone>004158 463 83 77</phone>
    <email>linda.muenger@agroscope.admin.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service of Endocrinology, Diabetes and Metabolism, University Hospital, CHUV</name>
      <address>
        <city>Lausanne</city>
        <state>VD</state>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François Pralong, MD</last_name>
      <phone>004121 314 05 96</phone>
      <email>francois.pralong@chuv.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <study_first_submitted>March 5, 2016</study_first_submitted>
  <study_first_submitted_qc>March 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2016</study_first_posted>
  <last_update_submitted>March 5, 2016</last_update_submitted>
  <last_update_submitted_qc>March 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire Vaudois</investigator_affiliation>
    <investigator_full_name>Francois Pralong</investigator_full_name>
    <investigator_title>Prof, MD</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

